| 1 |
33249990 | A drug repositioning success: The repositioned therapeutic applications and mechanisms of action of thalidomide. | 2021 Apr |
1 |
| 2 |
33517358 | Repurposing approved drugs for cancer therapy. | 2021 Mar 25 |
2 |
| 3 |
34512420 | TNF-Alpha as an Initiator of Allodynia and Anxiety-Like Behaviors in a Preclinical Model of PTSD and Comorbid Pain. | 2021 |
4 |
| 4 |
32935774 | Rationale use of Thalidomide in erythema nodosum leprosum - A non-systematic critical analysis of published case reports. | 2020 |
2 |
| 5 |
30362282 | Shedding light on IRIS: from Pathophysiology to Treatment of Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome in HIV-Infected Individuals. | 2019 Jan |
2 |
| 6 |
30736806 | TNF-α/STAT3 pathway epigenetically upregulates Nav1.6 expression in DRG and contributes to neuropathic pain induced by L5-VRT. | 2019 Feb 8 |
1 |
| 7 |
31464258 | Thalidomide-induced bronchiolitis obliterans organizing pneumonia in a patient with multiple myeloma. | 2019 Jul-Aug |
1 |
| 8 |
31819606 | Systemic Injection of Thalidomide Prevent and Attenuate Neuropathic Pain and Alleviate Neuroinflammatory Response in the Spinal Dorsal Horn. | 2019 |
1 |
| 9 |
31867326 | Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments. | 2019 |
2 |
| 10 |
29719394 | Preparation, characterization, in vitro and in vivo anti-tumor effect of thalidomide nanoparticles on lung cancer. | 2018 |
4 |
| 11 |
29732020 | Salivary levels of TNF-α in patients with recurrent aphthous stomatitis: A cross-sectional study. | 2018 Winter |
2 |
| 12 |
29854627 | Neuro- and nephroprotective effect of grape seed proanthocyanidin extract against carboplatin and thalidomide through modulation of inflammation, tumor suppressor protein p53, neurotransmitters, oxidative stress and histology. | 2018 |
1 |
| 13 |
30301277 | Synthesis and Biological Evaluation of Thalidomide Derivatives as Potential Anti-Psoriasis Agents. | 2018 Oct 7 |
1 |
| 14 |
28099781 | Old Drug Scaffold, New Activity: Thalidomide-Correlated Compounds Exert Different Effects on Breast Cancer Cell Growth and Progression. | 2017 Mar 7 |
1 |
| 15 |
28571559 | A Mini-Review on Thalidomide: Chemistry, Mechanisms of Action, Therapeutic Potential and Anti-Angiogenic Properties in Multiple Myeloma. | 2017 |
2 |
| 16 |
26440459 | LASSBio-1425, an analog of thalidomide, decreases triglyceride and increases HDL cholesterol levels by inhibition of TNF-α production. | 2016 Jan 1 |
1 |
| 17 |
26820153 | Thalidomide Improves the Intestinal Mucosal Injury and Suppresses Mesenteric Angiogenesis and Vasodilatation by Down-Regulating Inflammasomes-Related Cascades in Cirrhotic Rats. | 2016 |
1 |
| 18 |
26951036 | Treatment of refractory ulcerative necrobiosis lipoidica diabeticorum with oral thalidomide. | 2016 Jan-Feb |
1 |
| 19 |
27003992 | Effective treatment of gastrointestinal bleeding with thalidomide--Chances and limitations. | 2016 Mar 21 |
1 |
| 20 |
27492707 | The molecular mechanism of thalidomide analogs in hematologic malignancies. | 2016 Dec |
1 |
| 21 |
27556927 | Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum. | 2016 Aug |
1 |
| 22 |
25222109 | Possible roles of tumor necrosis factor-α and angiotensin II type 1 receptor on high glucose-induced damage in renal proximal tubular cells. | 2015 Feb |
1 |
| 23 |
25617013 | Review of thalidomide use in the pediatric population. | 2015 Apr |
2 |
| 24 |
25741973 | Clinicoradiologic response of neurologic tuberculous mass lesions in children treated with thalidomide. | 2015 Feb |
1 |
| 25 |
26220057 | Prolonged Suppression of Neuropathic Pain by Sequential Delivery of Lidocaine and Thalidomide Drugs Using PEGylated Graphene Oxide. | 2015 Nov |
1 |
| 26 |
26398114 | Therapeutic potential of thalidomide for gemcitabine-resistant bladder cancer. | 2015 Nov |
2 |
| 27 |
26486925 | TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature. | 2015 Nov-Dec |
1 |
| 28 |
24134145 | Rare atypical presentations in Type 2 lepra reaction: a case series. | 2014 Mar |
1 |
| 29 |
24275522 | Autism's cancer connection: the anti-proliferation hypothesis and why it may matter. | 2014 Jan |
2 |
| 30 |
24596000 | Thalidomide regulation of NF-κB proteins limits Tregs activity in chronic lymphocytic leukemia. | 2014 Jan-Feb |
2 |
| 31 |
24667589 | Mucosal healing with thalidomide in refractory Crohn's disease patients intolerant of anti-TNF-α drugs: report of 3 cases and literature review. | 2014 Jul |
3 |
| 32 |
24859059 | In vitro anti-proliferative and anti-angiogenic activities of thalidomide dithiocarbamate analogs. | 2014 Aug |
1 |
| 33 |
25531359 | Role of immunosuppressives in special situations: perianal disease and postoperative period. | 2014 |
1 |
| 34 |
22710762 | Thalidomide has anti-inflammatory properties in neonatal immune cells. | 2013 Feb |
1 |
| 35 |
23261764 | The up-regulation of IL-6 in DRG and spinal dorsal horn contributes to neuropathic pain following L5 ventral root transection. | 2013 Mar |
1 |
| 36 |
23583898 | Thalidomide attenuates excessive inflammation without interrupting lipopolysaccharide-driven inflammatory cytokine production in chronic granulomatous disease. | 2013 May |
1 |
| 37 |
23717811 | The combination of novel targeted molecular agents and radiation in the treatment of pediatric gliomas. | 2013 |
1 |
| 38 |
24284039 | Thalidomide distinctly affected TNF-α, IL-6 and MMP secretion by an ovarian cancer cell line (SKOV-3) and primary ovarian cancer cells. | 2013 Jul-Sep |
4 |
| 39 |
21681114 | Thalidomide use and outcomes in pediatric patients with Crohn disease refractory to infliximab and adalimumab. | 2012 Jan |
1 |
| 40 |
21883476 | Genetic variations in multiple myeloma II: association with effect of treatment. | 2012 Feb |
1 |
| 41 |
22277195 | TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. | 2012 Jan 25 |
1 |
| 42 |
22488443 | Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation. | 2012 Jun |
1 |
| 43 |
22650376 | Thalidomide: chemistry, therapeutic potential and oxidative stress induced teratogenicity. | 2012 |
2 |
| 44 |
22650377 | TNF α signaling beholds thalidomide saga: a review of mechanistic role of TNF-α signaling under thalidomide. | 2012 |
15 |
| 45 |
22731394 | 3,6'-Dithiothalidomide, a new TNF-α synthesis inhibitor, attenuates the effect of Aβ1-42 intracerebroventricular injection on hippocampal neurogenesis and memory deficit. | 2012 Sep |
1 |
| 46 |
22880820 | The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study. | 2012 Oct |
1 |
| 47 |
21215621 | Design, synthesis and biological evaluation of new thalidomide analogues as TNF-α and IL-6 production inhibitors. | 2011 Feb 1 |
3 |
| 48 |
21465313 | t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement. | 2011 Dec |
1 |
| 49 |
21511336 | Effects of thalidomide on long-term bone marrow cultures from patients with myelodysplastic syndromes: induction of IL-10 expression in the stromal layers. | 2011 Aug |
1 |
| 50 |
21792375 | Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of Inflammation. | 2011 |
4 |